Living with metastatic breast cancer can make Pinktober feel complicated. One patient reflects on awareness, research, loss and remembering the people behind the pink.
|Articles|October 27, 2021
Find Hereditary Cancer Studies and Participate in Research
FORCE’s Research Search and Enroll Tool can help patients find prevention, treatment and quality-of-life studies.
Advertisement
Are you a person with Lynch syndrome, an inherited mutation in BRCA1, BRCA2 or another gene? FORCE’s Research Search and Enroll Tool can help you find prevention, treatment and quality-of-life studies enrolling patients like you.
Advertisement
Related to this article
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
Learn how nipple-sparing mastectomy, including endoscopic approaches, may help preserve appearance, reduce scarring and support breast cancer recovery.
After 17 and a half years with metastatic primary peritoneal cancer, a former hospital executive explains how an AI health agent helped her after discharge.
Relatives of people with BRCA1 or BRCA2 variants completed genetic testing more often when a navigator reached out directly than when they received a letter.
The FDA approval is based on the phase 3 BRUIN CLL-313 trial, in which 94% of patients responded to Jaypirca compared with 81% who received chemoimmunotherapy.
Giredestrant plus Afinitor lowered the risk of cancer worsening or death by 62% in patients with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer.
Five-year results presented at ASTRO 2026 show a five-week radiation schedule after prostatectomy controls cancer as well as a seven-week course. But serious urinary side effects were more common.
Advertisement
Advertisement
Trending on CURE
1
Radiation Oncologist Answers Top Questions About Radiation Therapy
2
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
3
What Patients Should Know About Nipple-Sparing Mastectomy for Breast Cancer
4
Former Hospital Executive on Risks Patients With Cancer Face After Discharge
5